BFG
Bleakley Financial Group’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
77,088
+3,951
| +5% | +$68.4K | 0.03% | 352 |
|
|
2025
Q1 | $1.6M | Sell |
73,137
-368
| -0.5% | -$8.05K | 0.05% | 271 |
|
|
2024
Q4 | $2.35M | Sell |
73,505
-5,451
| -7% | -$174K | 0.07% | 228 |
|
|
2024
Q3 | $2.28M | Buy |
78,956
+210
| +0.3% | +$6.06K | 0.07% | 232 |
|
|
2024
Q2 | $3.02M | Buy |
78,746
+493
| +0.6% | +$18.9K | 0.09% | 208 |
|
|
2024
Q1 | $4.6M | Buy |
78,253
+7
| +0% | +$411 | 0.13% | 149 |
|
|
2023
Q4 | $4.68M | Sell |
78,246
-134
| -0.2% | -$8.02K | 0.15% | 130 |
|
|
2023
Q3 | $2.98M | Sell |
78,380
-307
| -0.4% | -$11.7K | 0.11% | 177 |
|
|
2023
Q2 | $7.17M | Sell |
78,687
-103,190
| -57% | -$9.4M | 0.22% | 88 |
|
|
2023
Q1 | $12M | Sell |
181,877
-561
| -0.3% | -$37K | 0.4% | 50 |
|
|
2022
Q4 | $9.43M | Buy |
+182,438
| New | +$9.43M | 0.34% | 59 |
|